On the basis of application, the DNA diagnostics market is segmented into oncology, forensics, pre and post natal genetic testing, infectious disease testing, and pharmacogenomics, among others. The rising prevalence of several types of cancers and the growing need to find causes and treatment options for the same has driven the deployment of DNA diagnostics in the oncology segment. Infectious disease testing also accounts for a considerable share of the demand owing to the rising incidence of infectious diseases.
The report studies the global market for DNA diagnostics on the basis of application, technology, and geography. Based on technology, the market is classified into microarrays, sequencing technology, polymerase chain reaction (PCR), in-situ hybridization, and mass spectrometry, among others.
Growing emphasis on the early detection and prevention of various diseases is the primary factor boosting the uptake of DNA diagnostics, notes Transparency Market Research in a report. The study, titled “DNA Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, observes the presence of a greater inclination toward genetic testing.
Download PDF brochure for this Report:
The rising incidence of genetic, chronic, and infectious diseases across the globe has spurred the need for effective and quick diagnostic methods, giving rise to the demand for DNA diagnostics. The increasing demand for cancer genetic testing and pharmacogenomics, technological advancements and the development of novel testing products, the growing popularity of personalized medicine, and an increased focus on prenatal and newborn screening and testing are some of the key factors driving the DNA diagnostics market. In contrast, high costs pertaining to R&D, stringent government regulations, and unclear reimbursement scenario in many countries deter the widespread adoption of DNA diagnostics.
By way of geography, the worldwide DNA diagnostics market comprises Europe, North America, Asia Pacific, and Rest of the World. North America accounts for a significant share in the overall market and rapid growth in this market can be attributed to the high prevalence of chronic diseases, increased funding for research and development in the field of DNA testing, favorable government initiatives, and the presence of well-established and advanced healthcare infrastructure. The DNA diagnostics market in Asia Pacific is also slated to witness strong growth over the course of the forecast period thanks to rapidly developing economies in the region. This translates to greater spending on healthcare, rising investments in medical science and research, introduction of newer technologies, and rising incentives provided by various governments, thereby driving the use of DNA diagnostic testing methods.
Cephide, Illumina, Inc., Roche Diagnostics, Sysmex, Bio-Rad Laboratories, Novartis, Johnson and Johnson, Bayer Diagnostic, Abbott Laboratories, Thermo Fisher Scientific, and Gene-probe Inc. are some of the key participants in the DNA diagnostics market. Most companies have been focused on R&D activities and on introducing accurate, more effective, and rapid DNA testing methods to detect genetic abnormalities. Strategic collaborations with diagnostic laboratories and hospitals is also an effective strategy observed in the DNA diagnostics market.
Browse Full Research Report on DNA Diagnostics Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.